Study Comparing Bioavailability of Oral Formulations of Vabicaserin

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Criteria

Inclusion Criteria:

• Healthy men aged 18-50 years.

Exclusion Criteria:

• Any significant disease state.

• History of drug or alcohol abuse within 1 year.

• Abnormal liver function tests.